SEC Filings | BioLineRx

Filing Date	Form	Description	View
Jan 19, 2021	424B5	Form of prospectus disclosing information, facts, events covered in both forms 424B2, 424B3	0001178913-21-000174.rtf 0001178913-21-000174.xls 0001178913-21-000174.pdf
Jan 19, 2021	FWP	FWP	0001178913-21-000176.rtf 0001178913-21-000176.pdf
Jan 11, 2021	EFFECT	EFFECT	9999999995-21-000115.rtf 9999999995-21-000115.xls 9999999995-21-000115.pdf
Jan 11, 2021	CORRESP	CORRESP	0001178913-21-000097.rtf 0001178913-21-000097.xls 0001178913-21-000097.pdf
Jan 06, 2021	SC 13G/A	An amendment to the SC 13G filing	0001535610-21-000036.rtf 0001535610-21-000036.pdf
Jan 06, 2021	UPLOAD	UPLOAD	0000000000-21-000121.rtf 0000000000-21-000121.pdf
Dec 31, 2020	424B5	Form of prospectus disclosing information, facts, events covered in both forms 424B2, 424B3	0001178913-20-003490.rtf 0001178913-20-003490.xls 0001178913-20-003490.pdf
Dec 31, 2020	F-3	Registration statement for certain foreign private issuers offered for certain transactions	0001178913-20-003492.rtf 0001178913-20-003492.xls 0001178913-20-003492.pdf
Dec 16, 2020	6-K	Report of foreign issuer rules 13a-16 and 15d-16 of the Securities Exchange Act	0001178913-20-003375.rtf 0001178913-20-003375.xls 0001178913-20-003375.pdf
Dec 16, 2020	6-K	Report of foreign issuer rules 13a-16 and 15d-16 of the Securities Exchange Act	0001178913-20-003377.rtf 0001178913-20-003377.xls 0001178913-20-003377.pdf

Data provided by Kaleidoscope.